Cobra toxin - ReceptoPharm

Drug Profile

Cobra toxin - ReceptoPharm

Alternative Names: Nyloxin Rx; Nyloxin Extra Strength

Latest Information Update: 13 Mar 2015

Price : $50

At a glance

  • Originator ReceptoPharm
  • Class Analgesics; Biological toxins; Cobra neurotoxin proteins
  • Mechanism of Action Nicotinic receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Pain

Most Recent Events

  • 13 Mar 2015 Cobra toxin - ReceptoPharm is still in the Preregistration phase for Pain in Canada, South America, Europe and India (PO and Topical)
  • 17 Oct 2011 No development reported - Preregistration for Pain in South America (PO)
  • 17 Oct 2011 No development reported - Preregistration for Pain in Europe (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top